These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34623382)

  • 21. A comprehensive update on the structure and synthesis of potential drug targets for combating the coronavirus pandemic caused by SARS-CoV-2.
    Malik P; Jain S; Jain P; Kumawat J; Dwivedi J; Kishore D
    Arch Pharm (Weinheim); 2022 May; 355(5):e2100382. PubMed ID: 35040187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro.
    Liao Q; Chen Z; Tao Y; Zhang B; Wu X; Yang L; Wang Q; Wang Z
    Sci Rep; 2021 Nov; 11(1):22796. PubMed ID: 34815498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
    Kar P; Kumar V; Vellingiri B; Sen A; Jaishee N; Anandraj A; Malhotra H; Bhattacharyya S; Mukhopadhyay S; Kinoshita M; Govindasamy V; Roy A; Naidoo D; Subramaniam MD
    J Biomol Struct Dyn; 2022 Jul; 40(10):4532-4542. PubMed ID: 33305988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
    Vardhan S; Sahoo SK
    Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational investigation for identification of potential phytochemicals and antiviral drugs as potential inhibitors for RNA-dependent RNA polymerase of COVID-19.
    Singh J; Malik D; Raina A
    J Biomol Struct Dyn; 2022 May; 40(8):3492-3507. PubMed ID: 33200678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2.
    Sharma K; Morla S; Goyal A; Kumar S
    Life Sci; 2020 Oct; 259():118169. PubMed ID: 32738360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets.
    Romeo I; Mesiti F; Lupia A; Alcaro S
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33530467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
    Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
    Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Sachdeva C; Wadhwa A; Kumari A; Hussain F; Jha P; Kaushik NK
    OMICS; 2020 Oct; 24(10):568-580. PubMed ID: 32757981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Situation of Small Molecules Targeting Key Proteins in combatting SARS-CoV-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications.
    Sorouri F; Emamgholipour Z; Keykhaee M; Najafi A; Firoozpour L; Sabzevari O; Sharifzadeh M; Foroumadi A; Khoobi M
    Mini Rev Med Chem; 2022; 22(2):273-311. PubMed ID: 33687881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
    Su X; Hu L; You Z; Hu P; Wang L; Zhao B
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
    Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
    Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.
    Batalha PN; Forezi LSM; Lima CGS; Pauli FP; Boechat FCS; de Souza MCBV; Cunha AC; Ferreira VF; da Silva FC
    Bioorg Chem; 2021 Jan; 106():104488. PubMed ID: 33261844
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Chandra A; Chaudhary M; Qamar I; Singh N; Nain V
    J Biomol Struct Dyn; 2022 Sep; 40(14):6534-6544. PubMed ID: 33583328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Traditional medicinal plants against replication, maturation and transmission targets of SARS-CoV-2: computational investigation.
    Mondal P; Natesh J; Abdul Salam AA; Thiyagarajan S; Meeran SM
    J Biomol Struct Dyn; 2022 Apr; 40(6):2715-2732. PubMed ID: 33150860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
    Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA
    Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic.
    Takahashi JA; Barbosa BVR; Lima MTNS; Cardoso PG; Contigli C; Pimenta LPS
    Bioorg Med Chem; 2021 Sep; 46():116366. PubMed ID: 34438338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspectives for repurposing drugs for the coronavirus disease 2019.
    Cherian SS; Agrawal M; Basu A; Abraham P; Gangakhedkar RR; Bhargava B
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):160-171. PubMed ID: 32317408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease.
    Llanes A; Cruz H; Nguyen VD; Larionov OV; Fernández PL
    Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33375460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.